3 results
Primary Objective To determine whether the combination of Onartuzumab + * erlotinib is superior (in terms of OS) to placebo * erlotinib after standard platinum-based chemotherapy in patients with Met diagnostic*positive non*small cell lung cancer (…
The objective of this monocenter, single-blinded, randomised controlled trial is to evaluate the effectiveness and cost-effectiveness of the Duckbill polyp snare in comparison with the hysteroscopic morcellator.Hypothesis: We hypothesize that snare…
Primary:* To assess the safety and tolerability of LAM-001 administered daily by dry powder inhaler (DPI) for 14 days in patients with lymphangioleiomyomatosis (LAM) (Period 1).* To assess the longer-term safety and tolerability of LAM-001…